A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial
Open accessThe DOI matches its Crossref record; 155 of the 160 references it cites were found in a registry or an index.
Abstract
Background: Insulin is generally administered to people with type 1 diabetes mellitus (T1DM) using multiple daily injections (MDIs), but can also be delivered using infusion pumps. In the UK, pumps are recommended for patients with the greatest need and adult use is less than in comparable countries. Previous trials have been small, of short duration and have failed to control for training in insulin adjustment. Objective: To assess the clinical effectiveness and cost-effectiveness of pump therapy compared with MDI for adults with T1DM, with both groups receiving equivalent structured training in flexible insulin therapy. Design: Pragmatic, multicentre, open-label, parallel-group cluster randomised controlled trial, including economic and psychosocial evaluations. After participants were assigned a group training course, courses were randomly allocated in pairs to either pump or MDI. Setting: Eight secondary care diabetes centres in the UK. Participants: Adults with T1DM for > 12 months, willing to undertake intensive insulin therapy, with no preference for pump or MDI, or a clinical indication for pumps. Interventions: Pump or MDI structured training in flexible insulin therapy, followed up for 2 years. MDI participants used insulin analogues. Pump participants used a Medtronic Paradigm®Veo TM(Medtronic, Watford, UK) with insulin aspart (NovoRapid, Novo Nordisk, Gatwick, UK). Main outcome measures: Primary outcome – change in glycated haemoglobin (HbA 1c) at 2 years in participants whose baseline HbA 1c was ≥ 7.5% (58 mmol/mol). Key secondary outcome – proportion of participants with HbA 1c≤ 7.5% at 2 years. Other outcomes at 6, 12 and 24 months – moderate and severe hypoglycaemia; insulin dose; body weight; proteinuria; diabetic ketoacidosis; quality of life (QoL); fear of hypoglycaemia; treatment satisfaction; emotional well-being; qualitative interviews with participants and staff (2 weeks), and participants (6 months); and ICERs in trial and modelled estimates of cost-effectiveness. Results: We randomised 46 courses comprising 317 participants: 267 attended a Dose Adjustment For Normal Eating course (132 pump; 135 MDI); 260 were included in the intention-to-treat analysis, of which 235 (119 pump; 116 MDI) had baseline HbA 1c of ≥ 7.5%. HbA 1c and severe hypoglycaemia improved in both groups. The drop in HbA 1c% at 2 years was 0.85 on pump and 0.42 on MDI. The mean difference (MD) in HbA 1c change at 2 years, at which the baseline HbA 1c was ≥ 7.5%, was –0.24% [95% confidence interval (CI) –0.53% to 0.05%] in favour of the pump (p = 0.098). The per-protocol analysis showed a MD in change of –0.36% (95% CI –0.64% to –0.07%) favouring pumps (p = 0.015). Pumps were not cost-effective in the base case and all of the sensitivity analyses. The pump group had greater improvement in diabetes-specific QoL diet restrictions, daily hassle plus treatment satisfaction, statistically significant at 12 and 24 months and supported by qualitative interviews. Limitation: Blinding of pump therapy was not possible, although an objective primary outcome was used. Conclusion: Adding pump therapy to structured training in flexible insulin therapy did not significantly enhance glycaemic control or psychosocial outcomes in adults with T1DM. Research priority: To understand why few patients achieve a HbA 1c of < 7.5%, particularly as glycaemic control is worse in the UK than in other European countries. Trial registration: Current Controlled Trials ISRCTN61215213. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 20. See the NIHR Journals Library website for further project information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intensive glycemic control with insulin therapy reduces the risk of these complications.200,1122,1123”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1123]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
The Discovery of Grounded Theory; Strategies for Qualitative Research
Glaser, B. G., Strauss, A. L., & Strutzel, E. (1968) · Nursing Research · doi:10.1097/00006199-196807000-00014 · Cited by 39,449
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Basics of Qualitative Research: Grounded Theory Procedures and Techniques
Long, D. R., Strauss, A., & Corbin, J. (1993) · The Modern Language Journal · doi:10.2307/328955 · Cited by 17,576
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392 · cited 1×
“The scores were standardised and scaled to range from 0 to 100, with higher scores representing better outcomes.(129,137)”
BackgroundEuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
An Efficient Method of Estimating Seemingly Unrelated Regressions and Tests for Aggregation Bias
Zellner, A. (1962) · Journal of the American Statistical Association · doi:10.1080/01621459.1962.10480664 · Cited by 8,401
Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment
THE WHOQOL GROUP (1998) · Psychological Medicine · doi:10.1017/s0033291798006667 · Cited by 7,933
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Research works printed but not linked: 24
- NICE, 2008, Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus
- NICE, 2013, Guide to the Methods of Technology Appraisal 2013
- Ray, 2013, Dose adjustment for normal eating (DAFNE) structured education reduces progression to continuous subcutaneous insulin infusion (CSII) among patients being considered for insulin pump therapy at enrolment, Diabet Med, 30, 7
- Nosadini, 1988, Frequency of hypoglycaemic and hyperglycaemic-ketotic episodes during conventional and subcutaneous continuous insulin infusion therapy in IDDM, Diabetes Nutr Metab Clin Exp, 1, 289
- Bacon, 2014, The effectiveness and safety of continuous subcutaneous insulin infusion in a large adult cohort over a 10 year period, Ir J Med Sci, 1, S450
- NICE, 2016, Integrated sensor-dugmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system)
- Zijlstra, 2015, Faster-acting insulin aspart by continuous subcutaneous insulin infusion: earlier exposure and greater early pharmacokinetic/pharmacodynamic effects vs. insulin aspart, Diabetologia, 1, S452
- Medical Research Council/DH/MHRA Joint Project, 2011, Risk-adapted Approaches to the Management of Clinical Trials of Investigational Medicinal Products
- Curtis, 2014, Unit Costs of Health and Social Care 2014
- DAFNE, 2012, DAFNE Fact Sheet Six
- Department of Health, 2014, NHS Reference Costs 2013 to 2014
- Department of Health, 2013, NHS Reference Costs 2012 to 2013
- Joint Formulary Committee, British National Formulary (online)
- Health and Social Care Information Centre, 2015, Prescription Cost Analysis England 2014
- London New Drugs Group, 2013, Comparative Table of Insulin Pumps
- Palmer JL. Cost-effectiveness of Angiotensin-converting Enzyme Inhibitors for the Prevention of Cardiovascular and End-stage Renal Disease in Patients with Type 1 Diabetes. 2012. PhD thesis. Sheffield: University of Sheffield; 2012.
- Joint Formulary Committee, 2012, British National Formulary
- Department of Health, 2011, NHS Reference Costs 2010–11
- The WHOQOL Group, 1996, WHOQOL-Bref: Introduction, Administration, Scoring and Generic Version of the Assessment
- Office for National Statistics, 2010, Standard occupational classification 2010
- Scottish Government, 2012, Scottish Index of Multiple Deprivation 2012
- NICE, Type 1 Diabetes in Adults: Diagnosis and Management
- Health and Social Care Information Centre, 2014, National Diabetes Audit 2012–13. Report 1: Care Processes and Treatment Targets
- SIGN, 2013, Management of Diabetes: A National Clinical Guideline
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Effects of sotagliflozin added to insulin in patients with type 1 diabetes
Garg, S. K., Henry, R. R., Banks, P., Buse, J. B., Davies, M. J., Fulcher, G. R., Pozzilli, P., Gesty-Palmer, D., Lapuerta, P., Simó, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708337 · Cited by 417
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Buse, J. B., Garg, S. K., Rosenstock, J., Bailey, T. S., Banks, P., Bode, B. W., Danne, T., Kushner, J. A., Lane, W. S., Lapuerta, P., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0343 · Cited by 234
“can increase DKA risk through operational or mechanical failures (35,36).”
BackgroundScott, G., Gillon, T. E., Pels, A., von Dadelszen, P., & Magee, L. A. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.018 · Cited by 159
Winkley, K., Upsher, R., Stahl, D., Pollard, D., Kasera, A., Brennan, A., Heller, S., & Ismail, K. (2020) · Health Technology Assessment · doi:10.3310/hta24280 · Cited by 136
Self-citationKwakkenbos, L., Imran, M., McCall, S. J., McCord, K. A., Fröbert, O., Hemkens, L. G., Zwarenstein, M., Relton, C., Rice, D. B., Langan, S. M., et al. (2021) · BMJ · doi:10.1136/bmj.n857 · Cited by 139
Self-citationFeig, D. S., Corcoy, R., Donovan, L. E., Murphy, K. E., Barrett, J. F. R., Sanchez, J. J., Wysocki, T., Ruedy, K., Kollman, C., Tomlinson, G., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1437 · Cited by 128
Self-citationChallenges in the design, planning and implementation of trials evaluating group interventions
Biggs, K., Hind, D., Gossage-Worrall, R., Sprange, K., White, D. A., Wright, J. T., Chatters, R., Berry, K., Papaioannou, D. E., Bradburn, M. J., et al. (2020) · Trials · doi:10.1186/s13063-019-3807-4 · Cited by 96
Self-citationSpeight, J., Choudhary, P., Wilmot, E. G., Hendrieckx, C., Forde, H., Cheung, W. Y., Crabtree, T., Millar, B., Traviss‐Turner, G., Hill, A., et al. (2023) · Diabetic Medicine · doi:10.1111/dme.14944 · Cited by 92
Nimri, R., Nir, J., & Phillip, M. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001097 · Cited by 94
Aae, T. F., Randsborg, P., Lurås, H., Årøen, A., & Lian, Ø. B. (2017) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-017-4802-5 · Cited by 69
Witteman, H. O., Vaisson, G., Provencher, T., Dansokho, S. C., Colquhoun, H. L., Dugas, M., Fagerlin, A., Giguere, A. M. C., Haslett, L., Hoffman, A. S., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/15032 · Cited by 63
The cost-effectiveness of osteochondral allograft transplantation in the knee
Mistry, H., Metcalfe, A. J., Smith, N., Loveman, E., Colquitt, J. L., Royle, P., & Waugh, N. R. (2019) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-019-05392-8 · Cited by 54
Self-citationCampbell, F., Lawton, J., Rankin, D., Clowes, M., Coates, E., Heller, S., de Zoysa, N., Elliott, J., & Breckenridge, J. P. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3655-z · Cited by 53
Self-citationBarriers to Uptake of Insulin Technologies and Novel Solutions
PAULEY, M. E., Berget, C., Messer, L. H., & Forlenza, G. P. (2021) · Medical Devices Evidence and Research · doi:10.2147/mder.s312858 · Cited by 73
Cartilage progenitor cells combined with PHBV in cartilage tissue engineering
Xue, K., Zhang, X., Gao, Z., Xia, W., Qi, L., & Liu, K. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1855-x · Cited by 48
Podiatry interventions to prevent falls in older people: a systematic review and meta-analysis
Wylie, G., Torrens, C., Campbell, P., Frost, H., Gordon, A. L., Menz, H. B., Skelton, D. A., Sullivan, F., Witham, M. D., & Morris, J. H. (2018) · Age and Ageing · doi:10.1093/ageing/afy189 · Cited by 44
Forlenza, G. P., Messer, L. H., Berget, C., Wadwa, R. P., & Driscoll, K. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1078-1 · Cited by 42
Holz, J., Spalding, T., Boutefnouchet, T., Emans, P. J., Eriksson, K., Brittberg, M., Konradsen, L. A. G., Kösters, C., VERDONK, P. C. M., Högström, M., et al. (2020) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-020-06289-7 · Cited by 42
Fabric Selection in Atopic Dermatitis: An Evidence-Based Review
Jaros, J., Wilson, C., & Shi, V. Y. (2020) · American Journal of Clinical Dermatology · doi:10.1007/s40257-020-00516-0 · Cited by 37
Maiorino, M. I., Bellastella, G., Casciano, O., Cirillo, P., Simeon, V., Chiodini, P., Petrizzo, M., Gicchino, M., Romano, O., Caruso, P., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0334 · Cited by 39
“05) in HbA1c levels favoring participants with insulin pump.(32) In contrast, two recent meta-analyses of RCTs concluded that use of insulin pump is more effective than MDI at decreasing HbA1c in adults with type 1 diabetes.”
Overcoming the Limitations of Stem Cell-Derived Beta Cells
Karimova, M. V., Gvazava, I. G., & Vorotelyak, E. A. (2022) · Biomolecules · doi:10.3390/biom12060810 · Cited by 35
Reidy, C., Bracher, M., Foster, C. L., Vassilev, I., & Rogers, A. E. (2018) · Health Expectations · doi:10.1111/hex.12666 · Cited by 36
Intensive Glycemic Treatment During Type 1 Diabetes Pregnancy: A Story of (Mostly) Sweet Success!
Murphy, H. R. (2018) · Diabetes Care · doi:10.2337/dci18-0001 · Cited by 30
Psychosocial Aspects of Diabetes Technology
Polonsky, W. H. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.003 · Cited by 29
Type 1 diabetes: where are we in 2017?
Copenhaver, M. M., & Hoffman, R. P. (2017) · Translational Pediatrics · doi:10.21037/tp.2017.09.09 · Cited by 34
Shinkins, B., Primrose, J. M., Pugh, S. A., Nicholson, B. D., Perera, R., James, T. J., & Mant, D. (2018) · British journal of surgery · doi:10.1002/bjs.10819 · Cited by 27
SCOTT, E. S., McGrath, R. T., Januszewski, A. S., Calandro, D., Hardikar, A. A., O'Neal, D. N., Fulcher, G. R., & Jenkins, A. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-033059 · Cited by 30
Pereira, E. V., Tonin, F. S., Carneiro, J., Pontarolo, R., & Wiens, A. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000196 · Cited by 25
“In addition, studies report an improvement in QoL (satisfaction with treatment) and symptoms of hypoglycemia in patients using an insulin infusion pump compared to those using multiple doses of insulin (three to four times a day) (31).”
MethodBrennan, M. C., Albrecht, M. A., Brown, J. A., Leslie, G. D., & Ntoumanis, N. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.01.001 · Cited by 26
Offorha, B. C., Walters, S. J., & Jacques, R. (2022) · Trials · doi:10.1186/s13063-022-06025-1 · Cited by 23
Wan, W., Skandari, M. R., Minc, A., Nathan, A. G., Zarei, P., Winn, A. N., O’Grady, M. J., & Huang, E. S. (2018) · Medical Decision Making · doi:10.1177/0272989x18803109 · Cited by 26
Thomas, M. G., Avari, P., Godsland, I. F., Lett, A. M., Reddy, M., & Oliver, N. S. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14498 · Cited by 23
Kim, S. J., Shetty, A. A., Kurian, N. M., Ahmed, S., Shetty, N. D., Stelzeneder, D., Shin, Y., Cho, Y. J., & Lee, S. H. (2020) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-020-05884-y · Cited by 20
Johnson, B., Norman, P. E., Sanders, T., Elliott, J., Whitehead, V., Campbell, F., Hammond, P., Ajjan, R., & Heller, S. R. (2019) · Diabetic Medicine · doi:10.1111/dme.14077 · Cited by 21
Self-citationLorenzen, J. T., Madsen, K. P., Cleal, B. R., Joensen, L. E., Nørgaard, K., Pedersen‐Bjergaard, U., Schmidt, S., Rytter, K., & Willaing, I. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080053 · Cited by 21
Lunati, M. E., Morpurgo, P. S., Rossi, A., Gandolfi, A., Cogliati, I., Bolla, A. M., Plebani, L., Vallone, L., Montefusco, L. B., Pastore, I., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.816599 · Cited by 18
“Starting new pump therapy does take extra effort from both the diabetes team and the patient (21).”
BackgroundMethodEvidence from clinical trials on high-risk medical devices in children: a scoping review
Guerlich, K., Patro-Gołąb, B., Dworakowski, P., Fraser, A. G., Kammermeier, M., Melvin, T., & Koletzko, B. V. (2023) · Pediatric Research · doi:10.1038/s41390-023-02819-4 · Cited by 17
Patient‐reported outcomes in studies of diabetes technology: What matters
Liarakos, A. L., Crabtree, T. S. J., & Wilmot, E. G. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15858 · Cited by 19
An, V. V., van den Broek, M., & Oussedik, S. I. (2017) · Knee Surgery and Related Research · doi:10.5792/ksrr.17.049 · Cited by 16
SGLT2 inhibitors as potentially helpful drugs in PI3K inhibitor-induced diabetes: a case report
Sahakian, N., Cattieuw, L., Ramillon-Cury, C., Corroller, A. B., Silvestre-Aillaud, P., Béliard, S., & Valéro, R. (2021) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-021-00125-8 · Cited by 13
Pasternak, Y., Lifshitz, D., Shulman, Y., Hiersch, L., Rimon, E., Kuperminc, M. J., Yogev, Y., & Ashwal, E. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05937-0 · Cited by 12
Continuous Subcutaneous Insulin Infusions: Closing the Loop
Díaz-Balzac, C. A., Pillinger, D., & Wittlin, S. D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac746 · Cited by 11
The impact of diabetes technology advances on quality of life: addressing the barriers to uptake
Kilvert, A., & Fox, C. (2023) · Practical Diabetes · doi:10.1002/pdi.2476 · Cited by 11
Polonsky, W. H., & Soriano, E. C. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231198533 · Cited by 8
Pickup, J. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.2503 · Cited by 8
“…not necessarily related to previous CSII experience: one center, with the largest number of participants, achieved a mean HbA1c difference of - 0.78% (95% confidence interval - 1.46% to - 0.09%), compared with the overall difference of - 0.24% for all centers (see the full report on the trial [4]).”
InfluentialThe Evolution of Insulin Administration in Type 1 Diabetes
Pinnaro, C. T., & Tansey, M. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.115021 · Cited by 9
“Several studies cite quality of life improvements on CSII therapy [88] [89] [90].”
BackgroundSarkodie, S. K., Wason, J. M. S., & Grayling, M. J. (2022) · Clinical Trials · doi:10.1177/17407745221123507 · Cited by 7
“1 Conservative value based on a previous trial Previous study Heller et al.(26) 0.”
MethodA tri-component knee plug for the 3rd generation of autologous chondrocyte implantation
Tayebi, L., Cui, Z., & Ye, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-73863-x · Cited by 7
Gong, Y., Wei, T., Liu, Y., Wang, J., Yan, J., Yang, D., Luo, S., Weng, J., & Zheng, X. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13558 · Cited by 6
“6,7 However, trials in women with pregestational diabetes have shown little agreement on the effect of CSII versus MDI on glycemic control and pregnancy outcomes.”
Precipitating Factors and Symptoms in Patients with Diabetic Ketoacidosis
Dragila, Ž. (2023) · Acta Clinica Croatica · doi:10.20471/acc.2023.62.01.08 · Cited by 10
“On the other hand, in a large randomized REPOSE trial, the use of an insulin pump versus multiple daily injections did not lead to significantly better glycemic control and better psychosocial status of the adult patients enrolled in that study 32 .”
BackgroundVallarino, C. R., Wong-Jacobson, S., Benneyworth, B. D., & Meadows, E. S. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211052081 · Cited by 4
Tourigny, C., Rey, É., Moreau, J., Guimond, M., Ouellet, A., Dubé, J., & Côté, A. (2020) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2020.08.019 · Cited by 3
A brief introduction to health economics
Waugh, N. R., & Mistry, H. (2019) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-019-05372-y · Cited by 3
Self-citationObradovic, M. M., Sudar-Milovanovic, E. M., Gluvic, Z. M., Gojobori, T., Essack, M., & Isenović, E. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_52 · Cited by 3
Factors determining the prognosis of people with type 1 diabetes – current perspective
Araszkiewicz, A., Trzaska, K., Soukharev, A., Spławski, J., Wolbach, J., Marek, P., Dubel, K., Wojak, W., & Zozulińska‐Ziółkiewicz, D. (2025) · Journal of Medical Science · doi:10.20883/medical.e1122 · Cited by 2
Martins, L. E. G., Neves, A. L. D., Tenório, F. S., & Cunha, T. S. (2021) · Revista Interfaces Saúde Humanas e Tecnologia · doi:10.16891/2317-434x.v9.e2.a2021.pp1034-1046 · Cited by 2
Psychosocial aspects of the usage of modern technologies in diabetes mellitus
Мотовилин, О. Г., Surkova, E. V., Самвеловна, Б. А., Ibragimova, L. I., & Mayorov, A. Y. (2019) · Diabetes Mellitus · doi:10.14341/dm9972 · Cited by 2
Yıldız, N., Nayki, U., Mete, B., Fadiloglu, K., Nergiz, A. İ., & Kocabaşoğlu, N. (2021) · COUNS-EDU| The International Journal of Counseling and Education · doi:10.23916/0020210633310 · Cited by 2
Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes
Barbara, A. M., & Grobelna, A. (2022) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2022.419 · Cited by 2
Wu, S., Jacques, R., & Walters, S. J. (2025) · Clinical Trials · doi:10.1177/17407745251378117 · Cited by 1
Reznik, Y., & Deberles, E. (2019) · Springer eBooks · doi:10.1007/978-3-319-98119-2_3 · Cited by 2
Provision of continuous subcutaneous insulin infusion to type 1 diabetes ‘frequent flyers’
Amato, L. A., Kalolo, R., Yu, W., & Simmons, D. S. (2023) · Internal Medicine Journal · doi:10.1111/imj.16213 · Cited by 1
Årøen, A., & Devitt, B. M. (2018) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-018-4852-3 · Cited by 1
Júnior, D. A. G., Sena, J. L., & Barroso, C. O. (2021) · Editora Omnis Scietia eBooks · doi:10.47094/978-65-88958-53-7/63-75
New Technologies for Insulin Administration
Forde, H. E., & Choudhary, P. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch33
Yee, J. (2024) · Clinical Research in Practice The Journal of Team Hippocrates · doi:10.22237/crp/1705536060
Emerging Role of Nitric Oxide in Pancreas and Pancreatic Islet Transplantation
Dugbartey, G. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-48067-6_15
Impacto del inicio de la monitorización flash de glucosa en pacientes adultos con diabetes tipo 1
Sahagún, R. J. (2024) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/72390
Verryn, M. T., & Cleary, S. (2025) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-025-00615-x
“Because insulin dosage is weight dependent, we modelled an adult T1DM population with a mean weight of 81.2 kg (SD 17.8) [29].”
InfluentialOfforha, B. C., Walters, S. J., & Jacques, R. (2022) · Figshare · doi:10.6084/m9.figshare.19126472
Offorha, B. C. (2023) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Araújo, S. T. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Grazhdankina, A. A., & Владимировна, К. Е. (2025) · Pharmacoeconomics theory and practice · doi:10.30809/phe.2.2025.1
Deshmukh, H., Shaikh, M., Wilmot, E. G., Kilpatrick, E., Chattopadhyay, S., Sathyapalan, T., & John, J. (2026) · Diabetic Medicine · doi:10.1111/dme.70401
“In contrast to improved glycaemic control with CSII shown by several trials, a UK-based REPOSE randomised controlled trial 28 found no significant difference in HbA1c outcomes between the two modalities when both groups received structured education, although pump therapy improved treatment…”
Heller, S. R., Scott, E., Elliott, J., Herbert, E., Rombach, I., Cooper, C. L., Brennan, A., Pollard, D. J., Lawton, J., Rankin, D., et al. (2025) · Programme Grants for Applied Research · doi:10.3310/gjsh0917 · Cited by 1
Self-citation
Metadata
- Authors
- Heller, S., White, D., Lee, E., Lawton, J., Pollard, D., Waugh, N., Amiel, S., Barnard, K., Beckwith, A., Brennan, A., Campbell, M., Cooper, C., Dimairo, M., Dixon, S., Elliott, J., Evans, M., Green, F., Hackney, G., Hammond, P., Hallowell, N., Jaap, A., Kennon, B., Kirkham, J., Lindsay, R., Mansell, P., Papaioannou, D., Rankin, D., Royle, P., Smithson, W. H., & Taylor, C.
- Affiliations
- University of Sheffield (GB)
- University of Edinburgh (GB)
- University of Warwick (GB)
- King's College London (GB)
- University of Southampton (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Academic Unit of Diabetes, Endocrinology and Metabolism, University of Sheffield, Sheffield, UK
- University of Cambridge (GB)
- Dumfries and Galloway Royal Infirmary (GB)
- Harrogate and District NHS Foundation Trust (GB)
- Edinburgh Royal Infirmary (GB)
- NHS Greater Glasgow and Clyde (GB)
- University of Glasgow (GB)
- Nottingham University Hospitals NHS Trust (GB)
- University College Cork (IE)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Heller, Simon
- ORCID
- Heller, Simon
- White, David
- Lee, Ellen
- Lawton, Julia
- Pollard, Daniel
- Waugh, Norman
- Amiel, Stephanie
- Brennan, Alan
- Campbell, Michael
- Cooper, Cindy
- Dimairo, Munyaradzi
- Dixon, Simon
- Evans, Mark
- Hackney, Gemma
- Hammond, Peter
- Hallowell, Nina
- Jaap, Alan
- Kennon, Brian
- Kirkham, Jackie
- Lindsay, Robert
- Papaioannou, Diana
- Rankin, David
- Royle, Pamela
- Venue
- Health Technology Assessment
- Published
- 2017-04
- Volume
- 21
- Issue
- 20
- Pages
- 1-278
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- PMC
- PMC5421095
- OpenAlex
- W2607776465
- Cited by
- 73
- References
- 160
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 13 · 2020: 10 · 2019: 9 · 2018: 12 · 2017: 4
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Cork Open Research Archive (University College Cork, Ireland) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Health Technology Assessment programme (08/107/01)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, insulin pump therapy, multiple daily insulin injections, HbA1c, hypoglycemia, cost-effectiveness, quality of life, fear of hypoglycemia, insulin aspart, insulin analogues, diabetes self-management education, emotional well-being
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Body Weight, Cost-Benefit Analysis, Diabetes Mellitus, Type 1, Dose-Response Relationship, Drug, Female, United Kingdom, Glycated Hemoglobin, Humans, Hypoglycemia, Insulin, Insulin Infusion Systems, Male, Middle Aged, Proteinuria, Quality of Life, State Medicine, Technology Assessment, Biomedical, Diabetic Ketoacidosis, Quality-Adjusted Life Years, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.